SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors | MicrobiomeTrials← Back to trialsNCT07646626
SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-07-17Est. Completion: 2027-06-30
Enrollment target: 150 participants Locations- Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Other microbiome trials you might be interested in
FGFR2 Gene Fusion/RearrangementOther Solid Tumors, Adult
The goal of this clinical trial is to evaluate if lirafugratinib is efficacious and safe to treat adult patients with pr…
Phoenix, United StatesEst. completion Sep 2027
Locally Advanced Adrenal Cortical CarcinomaMetastatic Adrenal Cortical CarcinomaRecurrent Adrenal Cortical CarcinomaStage III Adrenal Cortical Carcinoma AJCC v8Stage IV Adrenal Cortical Carcinoma AJCC v8
Unresectable Adrenal Cortical Carcinoma
This phase II trial compares the effect of giving cabozantinib with or without cemiplimab in patients with adrenocortica…
La Jolla, United StatesEst. completion Jun 2, 2029